ABSTRACT
In light of recent developments, a great deal of new material on the acute coronary syndrome (ACS) has been published in the last few years. The data focuses on the best treatment for the ACS patient in addition to diagnosis, prognosis, and risk stratification (1,2). The importance of this information is based on the prevalence of ACS and its complications (3). Nearly 1.7 million patients are hospitalized every year in the United States with ACS (4). Nearly 20 years ago, it was discussed that angiographic morphology of the stenosis was more important than the stenosis severity (5). From this angiographic viewpoint, clinical, biochemical, and histological information has developed for ACS patients.
